Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

1.75
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.75
-32.69%
Year-to-Date

Today’s Trading

Previous close1.75
Today’s open1.75
Day’s range1.55 - 1.80
Volume3,229,152
Average volume (3 months)1,959,592
Market cap$79.4M
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-58.33%
Earnings growth (this year)-14.74%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)-9.89%
P/E ratioNM
Price/Sales6.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...+0.31+8.12%
CEMPCempra Inc-0.02-0.85%
RDHLRedhill Biopharma Lt...+0.07+0.80%
TRVNTrevena Inc-0.17-9.29%
Data as of 3:59pm ET, 10/19/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$17.4M
Annual profit (last year)-$43.2M
Net profit margin-248.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Vincent J. Angotti
Chief Financial Officer
Raffi Asadorian
Corporate headquarters
Redwood City, California

Forecasts